Atlas Trials

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Clinical trial NCT04059198 · TERMINATED

Trial details

NCT number
NCT04059198
Sponsor
F-star Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis BHBVHepatitis B, Chronic
Start date
2019-10-10
Primary completion
2020-04-02
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.